Jacqui Eales1, Peter Gibson2, Peter Whorwell3, John Kellow4, Ann Yellowlees5, Richard H J Perry5, Mary Edwards1, Sarah King1, Hannah Wood1, Julie Glanville6. 1. York Health Economics Consortium, University of York, Heslington, York, UK. 2. Monash University, Alfred Hospital, Melbourne, Australia. 3. Wythenshawe Hospital, Manchester, UK. 4. University of Sydney, Royal North Shore Hospital, Sydney, Australia. 5. Quantics Consulting Ltd, Edinburgh, Scotland. 6. York Health Economics Consortium, Enterprise House, Innovation Way, University of York, Heslington, York YO10 5NQ, UK.
Abstract
BACKGROUND: It has been suggested that probiotics may improve gastrointestinal discomfort. Not all probiotics exhibit the same effects and consequently meta-analyses on probiotics should be confined to well-defined strains or strain combinations. The aim of this study was to evaluate the effectiveness of a probiotic fermented milk (PFM) that includes Bifidobacterium lactis (B. lactis) CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population. METHODS: Double-blind randomized controlled trials in the general adult population comparing PFM with a control dairy product for at least 4 weeks were searched from multiple literature databases (up to February 2015). Meta-analyses using random-effects models, with individual participant data were undertaken to calculate an odds ratio (OR) or standard mean difference (SMD), with a 95% confidence interval (CI). RESULTS: The search strategy identified 12,439 documents. Overall, three trials with a total of 598 adults (female = 96.5%) met the inclusion criteria. Consumption of the PFM product was associated with a significant improvement in overall gastrointestinal discomfort compared with the control product (OR = 1.48; 95% CI 1.07-2.05), with a number needed to treat (NNT) of 10.24 (95% CI 5.64-55.93). PFM was also superior to the control in reducing digestive symptoms, as measured using a composite score (SMD = -0.21; 95% CI -0.37 to -0.05). Sensitivity analyses produced similar results, and the heterogeneity between studies was minimal. CONCLUSIONS: This meta-analysis shows that the consumption of PFM with B. lactis CNCM I-2494 and lactic acid bacteria is associated with a modest but consistent and significant improvement of outcomes related to gastrointestinal discomfort in healthy adults.
BACKGROUND: It has been suggested that probiotics may improve gastrointestinal discomfort. Not all probiotics exhibit the same effects and consequently meta-analyses on probiotics should be confined to well-defined strains or strain combinations. The aim of this study was to evaluate the effectiveness of a probiotic fermented milk (PFM) that includes Bifidobacterium lactis (B. lactis) CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population. METHODS: Double-blind randomized controlled trials in the general adult population comparing PFM with a control dairy product for at least 4 weeks were searched from multiple literature databases (up to February 2015). Meta-analyses using random-effects models, with individual participant data were undertaken to calculate an odds ratio (OR) or standard mean difference (SMD), with a 95% confidence interval (CI). RESULTS: The search strategy identified 12,439 documents. Overall, three trials with a total of 598 adults (female = 96.5%) met the inclusion criteria. Consumption of the PFM product was associated with a significant improvement in overall gastrointestinal discomfort compared with the control product (OR = 1.48; 95% CI 1.07-2.05), with a number needed to treat (NNT) of 10.24 (95% CI 5.64-55.93). PFM was also superior to the control in reducing digestive symptoms, as measured using a composite score (SMD = -0.21; 95% CI -0.37 to -0.05). Sensitivity analyses produced similar results, and the heterogeneity between studies was minimal. CONCLUSIONS: This meta-analysis shows that the consumption of PFM with B. lactis CNCM I-2494 and lactic acid bacteria is associated with a modest but consistent and significant improvement of outcomes related to gastrointestinal discomfort in healthy adults.
Authors: Nathan P McNulty; Tanya Yatsunenko; Ansel Hsiao; Jeremiah J Faith; Brian D Muegge; Andrew L Goodman; Bernard Henrissat; Raish Oozeer; Stéphanie Cools-Portier; Guillaume Gobert; Christian Chervaux; Dan Knights; Catherine A Lozupone; Rob Knight; Alexis E Duncan; James R Bain; Michael J Muehlbauer; Christopher B Newgard; Andrew C Heath; Jeffrey I Gordon Journal: Sci Transl Med Date: 2011-10-26 Impact factor: 17.956
Authors: D Guyonnet; O Chassany; P Ducrotte; C Picard; M Mouret; C-H Mercier; C Matuchansky Journal: Aliment Pharmacol Ther Date: 2007-08-01 Impact factor: 8.171
Authors: Magnus Simrén; Giovanni Barbara; Harry J Flint; Brennan M R Spiegel; Robin C Spiller; Stephen Vanner; Elena F Verdu; Peter J Whorwell; Erwin G Zoetendal Journal: Gut Date: 2012-06-22 Impact factor: 23.059
Authors: Gabriele Andrea Lugli; Walter Mancino; Christian Milani; Sabrina Duranti; Leonardo Mancabelli; Stefania Napoli; Marta Mangifesta; Alice Viappiani; Rosaria Anzalone; Giulia Longhi; Douwe van Sinderen; Marco Ventura; Francesca Turroni Journal: Appl Environ Microbiol Date: 2019-03-22 Impact factor: 4.792
Authors: A P S Hungin; C R Mitchell; P Whorwell; C Mulligan; O Cole; L Agréus; P Fracasso; C Lionis; J Mendive; J-M Philippart de Foy; B Seifert; K-A Wensaas; C Winchester; N de Wit Journal: Aliment Pharmacol Ther Date: 2018-02-20 Impact factor: 8.171
Authors: Bárbara F Cordeiro; Emiliano R Oliveira; Sara H da Silva; Bruna M Savassi; Leonardo B Acurcio; Luisa Lemos; Juliana de L Alves; Helder Carvalho Assis; Angélica T Vieira; Ana M C Faria; Enio Ferreira; Yves Le Loir; Gwénaël Jan; Luiz R Goulart; Vasco Azevedo; Rodrigo D de O Carvalho; Fillipe L R do Carmo Journal: Front Microbiol Date: 2018-09-12 Impact factor: 5.640
Authors: Chad M Cullen; Kawalpreet K Aneja; Sinem Beyhan; Clara E Cho; Stephen Woloszynek; Matteo Convertino; Sophie J McCoy; Yanyan Zhang; Matthew Z Anderson; David Alvarez-Ponce; Ekaterina Smirnova; Lisa Karstens; Pieter C Dorrestein; Hongzhe Li; Ananya Sen Gupta; Kevin Cheung; Jennifer Gloeckner Powers; Zhengqiao Zhao; Gail L Rosen Journal: Front Microbiol Date: 2020-02-19 Impact factor: 5.640
Authors: Bruna Savassi; Bárbara F Cordeiro; Sara H Silva; Emiliano R Oliveira; Giovanna Belo; Alessandra Gomes Figueiroa; Maria Izabel Alves Queiroz; Ana Maria Caetano Faria; Juliana Alves; Tales Fernando da Silva; Gabriela Munis Campos; Erick A Esmerino; Ramon S Rocha; Monica Q Freitas; Marcia C Silva; Adriano G Cruz; Kátia Duarte Vital; Simone O A Fernandes; Valbert N Cardoso; Leonardo Borges Acurcio; Gwénaël Jan; Yves Le Loir; Alfonso Gala-Garcia; Fillipe Luiz R do Carmo; Vasco Azevedo Journal: Front Pharmacol Date: 2021-12-10 Impact factor: 5.810